Description
Active Ingredient: Available in 100 mg dose; this impotence treating medicine serves as one of the quality enriched medical treatments that shall fight repeated penile failures and enjoy lovemaking sessions without any worries. The medicine shall serve as being one of the amazing formulas so as to deal with sexual dysfunction and experience pleasure with enhanced action mechanism.
Indication: The conventional tablet is the right drug of choice in impotence situation, as it looks after enhancing blood flow to the penile organ with the help of its active component – Sildenafil Citrate. This prescription medicine needs to be used only after consulting a healthcare professional. This solution is extremely effective in helping men to produce a stiffer and durable penile erection.
Action Mechanism: The pharmacological action of Siltrate Citrate is a bit intricate. Post-oral consumption, the active Sildenafil Citrate in the pill targets and negates the function of an enzyme known as PDE5. The level of nitric oxide is significantly boosted on inhibition of PDE5. When this action occurs, the arteries shall dilate and muscles might relax, which shall improve the blood flow. This way the penile shaft might receive enough amount of blood to make the tissues strong for an erection. Siltrate shall initiate the erection process only in the presence of complete sexual stimulation.
Dosages: Effectiveness of the high dosage Sildenafil Citrate 100 mg composed brand Siltrate pill might help men in staying active in the body for about 4 to 6 hours. The medicine is available in one dosage mentioned below:
- 100 mg: Swallow the conventional tablet approx. 30 minutes before planned lovemaking session in the presence of sexual stimulation for maximum outcomes
Note: Medicine Siltrate is same as in other ED branded medications. It works well by dealing with impotence issue in men. The effects of the pill are 100% proven when consumed as prescribed and they do not lead to any setbacks or penile failure.
Reviews
There are no reviews yet.